FACTBOX-Major drugmakers turn to China for licensing deals

(Changes dateline, rewrites lede and headline, adds European drugmakers to the list throughout) Sept 30 (Reuters) – Novo Nordisk said on Tuesday it will pay up to $2.6 billion to Jiangsu Hengrui

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)